Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy — Stella
Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(15 sites)
Germany
Universitätsklinikum Augsburg, Augsburg
Hochtaunus-Kliniken Bad Homburg, Bad Homburg
Universitätsklinikum Carl Gustav Carus Dresden, Dresden
Universitätsklinikum Düsseldorf, Düsseldorf
KEM Kliniken Essen-Mitte, Essen
Universitätsklinikum Essen, Essen
Universitätsmedizin Göttingen, Göttingen
University Hospital Hamburg, Hamburg
Klinikum Hanau GmbH, Hanau
ZAGO - Zentrum für ambulante gynäkologische Onkologie, Krefeld